CH25H Antibodies

Santa Cruz Biotechnology supplies a comprehensive collection of CH25H monoclonal antibodies for investigating cholesterol 25-hydroxylase (CH25H) in various biological processes. CH25H monoclonal antibodies are suitable for multiple applications, including western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). CH25H is a key enzyme involved in cholesterol metabolism, converting cholesterol into 25-hydroxycholesterol, which plays a significant role in regulating immune responses and inflammation. CH25H maintains cellular homeostasis and has been linked to various diseases, including atherosclerosis and certain cancers. Research focused on CH25H can provide valuable insights into potential therapeutic targets for these conditions. Scientists worldwide use CH25H monoclonal antibodies to explore cholesterol metabolism pathways and their impact on cellular function. Understanding CH25H activity helps reveal its role in both normal physiological processes and disease states. CH25H monoclonal antibodies from Santa Cruz Biotechnology enable researchers to advance scientific knowledge in cholesterol metabolism and contribute to the development of new therapeutic strategies.